Abstract Background: Since the COVID-19 outbreak, global efforts have focused on controlling the disease. However, intense cross border movements pose a risk for the emergence of new SARS-CoV-2 strains. Recent example is the detection of cases among the 2024 Senegalese pilgrims returning from Mecca, Saudi Arabia, to monitor the emergence of high-threat strains. This study aims investigate new SARS-CoV-2 emerging lineages isolated from returning Senegalese Pilgrims. Methods: Whole Genome Sequencing, using midnight protocol on Oxford Nanopore Technology (ONT) platform, has been used to characterize SARS-CoV-2 strains isolated from 66 pilgrims tested Covid-19 positive. An integrated approach, involving strong collaboration with the Ministry of Health (MoH), was utilized for data sharing with patients and healthcare authorities. Results: Among 66 positive samples sequenced with coverage ≥ 80%, we detected the presence of the JN.1 sub-lineage (12.71%) and the emergence of the JN.1.18 variant (4.24%). In addition, JN.1.18.3 (14.41%) elicited more mutations than JN.1. Furthermore, we also identified variants, LF.1.1.1 (4.24%), JN.1.26 (1.69%), KP.1.1.1 (5.08%), KP.1.1.3 (1.69%), LP.2 (2.54%), JN.1.50.1 (0.85%), LB.1 (0.85%), and KS.1.1 (0.85%) which have never been identified in Africa in our knowledge. New lineages LS.1 (2.54%) and JN.1.18.5 (2.54%) were identified in real time during this intervention. Conclusion: It is important to monitor the emergence of new variants among pilgrims and the general population, as well as the clinical course of patients, to determine the virulence of these variants.
No takes yet. Share an insight, caveat, or question.
Padane et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: